| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046942365 |
| P356 | DOI | 10.1038/SREP21719 |
| P8608 | Fatcat ID | release_e276i7h7trexvousyvnnxcbrka |
| P932 | PMC publication ID | 4761982 |
| P698 | PubMed publication ID | 26898832 |
| P5875 | ResearchGate publication ID | 295688784 |
| P50 | author | Merve Avar | Q93365964 |
| P2093 | author name string | Randi J Hagerman | |
| John M Olichney | |||
| Jin-Chen Yang | |||
| Yu-Qiong Niu | |||
| Jim Grigsby | |||
| Annette Rodriguez | |||
| Ashley Royston | |||
| Christa Simon | |||
| Ryan Brill | |||
| P2860 | cites work | Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers | Q43842059 |
| Dopamine modulates involuntary attention shifting and reorienting: an electromagnetic study | Q44237423 | ||
| Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice | Q44374774 | ||
| Memantine in moderate-to-severe Alzheimer's disease | Q44388745 | ||
| Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation | Q44521568 | ||
| Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). | Q46007399 | ||
| N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia | Q46241563 | ||
| The effects of lesions of superior temporal gyrus and inferior parietal lobe on temporal and vertex components of the human AEP. | Q46362432 | ||
| Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. | Q46601293 | ||
| Effects of NMDA receptor antagonist memantine on mismatch negativity | Q48192314 | ||
| Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats | Q48248694 | ||
| Effects of dizocilpine (MK-801) and ethanol on the EEG and event-related potentials (ERPS) in rats | Q48499040 | ||
| The duality of selection: excitatory and inhibitory processes in auditory selective attention | Q48611469 | ||
| EEG and ERP assessment of normal aging | Q48713448 | ||
| Inhibiting change: effects of memory on auditory selective attention | Q48770597 | ||
| Aging-related changes in processing of non-target and target stimuli during an auditory oddball task. | Q50860729 | ||
| Control of working memory: effects of attention training on target recognition and distractor salience in an auditory selection task. | Q50982290 | ||
| Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. | Q51894749 | ||
| The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. | Q51936552 | ||
| Midlatency auditory event-related potentials in mice: comparison to midlatency auditory ERPs in humans. | Q51998622 | ||
| Reduction of P3b in patients with temporo-parietal lesions | Q72447929 | ||
| Maturation of human central auditory system activity: evidence from multi-channel evoked potentials | Q73461109 | ||
| Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function | Q80826340 | ||
| Memantine: New prospective in bipolar disorder treatment | Q26852133 | ||
| Fragile X-associated tremor/ataxia syndrome | Q26852667 | ||
| The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis | Q28143881 | ||
| Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study | Q30426960 | ||
| Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study | Q30593573 | ||
| Mechanisms of human attention: event-related potentials and oscillations | Q30662212 | ||
| The role of biomarkers in clinical trials for Alzheimer disease | Q31032781 | ||
| Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited | Q33604446 | ||
| Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine | Q33617773 | ||
| The relationship between working memory capacity and executive functioning: evidence for a common executive attention construct | Q33781398 | ||
| Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome | Q33808428 | ||
| The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome. | Q33901895 | ||
| CNTRICS final biomarker selection: Control of attention | Q33963429 | ||
| An fMRI study of the prefrontal activity during the performance of a working memory task in premutation carriers of the fragile X mental retardation 1 gene with and without fragile X-associated tremor/ataxia syndrome (FXTAS). | Q34297704 | ||
| Memantine agonist action at dopamine D2High receptors | Q34713522 | ||
| Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. | Q34977377 | ||
| Selective executive markers of at-risk profiles associated with the fragile X premutation | Q35173554 | ||
| A review of the evidence for P2 being an independent component process: age, sleep and modality | Q35683605 | ||
| Quantifying the information value of clinical assessments with signal detection theory | Q35687437 | ||
| Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. | Q36026897 | ||
| Prevalence of CGG expansions of the FMR1 gene in a US population-based sample | Q36082674 | ||
| Signaling defects in iPSC-derived fragile X premutation neurons | Q36142068 | ||
| CGG trinucleotide repeat length modulates neural plasticity and spatiotemporal processing in a mouse model of the fragile X premutation | Q36253268 | ||
| The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance | Q36966622 | ||
| No evidence for a difference in neuropsychological profile among carriers and noncarriers of the FMR1 premutation in adults under the age of 50 | Q37156229 | ||
| A multimodal imaging analysis of subcortical gray matter in fragile X premutation carriers | Q37204665 | ||
| Phenotypes of hypofrontality in older female fragile X premutation carriers | Q37529887 | ||
| Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome | Q37580522 | ||
| Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research. | Q37799406 | ||
| The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence | Q38025454 | ||
| The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components | Q40506415 | ||
| Assessment of auditory sensory processing in a neurodevelopmental animal model of schizophrenia--gating of auditory-evoked potentials and prepulse inhibition | Q43086404 | ||
| Dose-related effects of memantine on a mismatch negativity-like response in anesthetized rats. | Q43125039 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fragile X-associated tremor/ataxia syndrome | Q1440436 |
| attention | Q6501338 | ||
| P304 | page(s) | 21719 | |
| P577 | publication date | 2016-02-22 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial | |
| P478 | volume | 6 |
| Q47140616 | Fragile X syndrome and fragile X-associated disorders. |
| Q33639492 | Fragile X-Associated Tremor/Ataxia Syndrome: From Molecular Pathogenesis to Development of Therapeutics |
| Q55383378 | Fragile X-Associated Tremor/Ataxia Syndrome: Unmet Needs and a Path for the Future. |
| Q38875623 | Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management |
| Q38880460 | Fragile X-associated tremor/ataxia syndrome: another phenotype of the fragile X gene |
| Q47743043 | Fragile X-associated tremor/ataxia syndrome: cognitive presentations |
| Q40046008 | Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force. |
| Q91918711 | [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment] |
Search more.